Impact of bacteremia on the pathogenesis of experimental pneumococcal meningitis

Christian T Brandt1, David Holm, Matthew Liptrot

  • 1National Center for Antimicrobials and Infection Control, Faculty of Health Sciences, University of Copenhagen, Copenhagen, Denmark. ctb@ssi.dk

Abstract

Insights

Bacteremia significantly impacts pneumococcal meningitis outcomes. Reducing bacteremia improved symptoms and reduced brain swelling and blood-brain barrier damage in rats.

Area of Science:

  • Neuroscience
  • Infectious Diseases
  • Pathophysiology

Background:

  • Bacteremia is a critical factor influencing the prognosis of pneumococcal meningitis.
  • Understanding the impact of systemic infection on brain pathophysiology is essential.

Purpose of the Study:

  • To investigate the influence of bacteremia on the brain's pathophysiologic profile in experimental pneumococcal meningitis.
  • To assess the effects of attenuated and early-onset bacteremia on brain injury markers.

Main Methods:

  • Rats with Streptococcus pneumoniae meningitis were divided into three groups: attenuated bacteremia, early-onset bacteremia, and meningitis control.
  • Magnetic resonance imaging (MRI) was used to evaluate blood-brain barrier (BBB) breakdown, ventricle size, and brain edema.
  • Clinical disease scores and laboratory data were collected.

Main Results:

  • Attenuation of bacteremia significantly improved clinical symptoms and reduced ventricle expansion and BBB breakdown.
  • Early-onset bacteremia did not exacerbate ventricle enlargement or BBB leakage.
  • Both attenuated and early-onset bacteremia led to significantly increased brain edema.

Conclusions:

  • While focal brain lesions stem from local meningeal infection, systemic infection (bacteremia) significantly contributes to clinical presentation, BBB breakdown, and ventricle expansion.
  • Future research should differentiate the effects of systemic and local infectious processes on meningitis outcomes.

Related Concept Videos

Bacterial Meningitis01:24

Bacterial Meningitis

Bacterial meningitis is a severe infectious disease involving inflammation of the meninges, the protective membranes surrounding the brain and spinal cord. It occurs when pathogenic bacteria cross the blood–brain barrier and enter the cerebrospinal fluid. Common causative organisms include Neisseria meningitidis, Streptococcus pneumoniae, Haemophilus influenzae type b, Listeria monocytogenes, and Escherichia coli K1. The exact route of entry varies by pathogen and host condition.Routes of Entry...
Bacterial Meningitis II: Pathophysiology01:26

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...
Bacterial Meningitis I: Introduction01:22

Bacterial Meningitis I: Introduction

Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Determinants of Bacterial Pathogenicity and Virulence01:20

Determinants of Bacterial Pathogenicity and Virulence

Pathogenic bacteria employ a variety of strategies to establish infections, including the secretion of extracellular enzymes that act as potent virulence factors. These enzymes facilitate bacterial colonization of host tissues and help evade immune surveillance. By targeting structural components of host tissues and interfering with immune mechanisms, these enzymes play a pivotal role in disease progression.Extracellular Enzymes Facilitating Tissue Invasion: Several bacterial pathogens secrete...